Leading the Way in Life Science Technologies

GEN Exclusives

More »

January 1, Vol. 28, No. 1

  • Columns

    • DTC Campaigns Mislead Public
    • Karina Brierley
      Ellen Matloff
    • In September, Myriad Genetics Laboratories launched a direct to consumer (DTC) campaign aggressively advertising its BRACAnalysis testing The company holds an exclusive patent on genetic testing for the BRCA1 and BRCA2 genes for hereditary breast and ovarian cancer The advertising ... more »
    • Making Personalized Medicine a Reality
    • Lisa A. Haile
    • Healthcare spending per capita in the US is much higher than in other countries, according to the Organisation for Economic Co-operation and Development It is reportedly at least 24% more than the next highest spending countries and over 90% higher ... more »
    • Expanding Antibody Therapeutic Options
    • Carol Potera
    • Based in Heidelberg, Germany, Affimed Therapeutics (wwwaffimedcom) specializes in the development of second-generation mAbs targeted at the treatment of cancer and other diseases with unmet medical needs Biochemist Melvyn Little, PhD, created the company’s technology platform in the 1990s when ... more »